Marshall Fordyce, M.D.

Marshall Fordyce, M.D.

President and Chief Executive OfficeratVera Therapeutics· In proxies 2022–2025

Pay in FY2025+24% from the year before · Vera Therapeutics stock +19.7% the same year

Marshall Fordyce, M.D. was paid $7.0M in FY2025 (Dec), up 24%. Vera Therapeutics stock rose 19.7% that year.

Pay$100 in the stock at the end of FY21 → $190
Pay is from the Summary Compensation Table of each Vera Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Vera TherapeuticsPublic company · 4 yr
    • President and Chief Executive Officer2022 – Present · 4 yrStock in role +37%
  2. AlbertPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?